The release of serum proteins and dye from glass ionomer (polyalkenoate) and acrylic cements: a pilot study

1994 ◽  
Vol 5 (9-10) ◽  
pp. 711-714 ◽  
Author(s):  
C. Wittwer ◽  
A. J. Devlin ◽  
P. V. Hatton ◽  
I. M. Brook ◽  
S. Downes
Author(s):  
Anders Esberg ◽  
Catrine Isehed ◽  
Anders Holmlund ◽  
Susanne Lindquist ◽  
Pernilla Lundberg

2003 ◽  
Vol 31 (4) ◽  
pp. 314-319 ◽  
Author(s):  
Dia Taifour ◽  
Jo E. Frencken ◽  
Martin A. Van′t Hof ◽  
Nabil Beiruti ◽  
Gert-Jan Truin
Keyword(s):  

2010 ◽  
Vol 35 (2) ◽  
pp. 157-161 ◽  
Author(s):  
Sajad Sainulabdeen ◽  
Prasanna Neelakantan ◽  
Sindhu Ramesh ◽  
CV Subbarao

Objectives: The aim of this pilot study was to evaluate the antibacterial activity of glass ionomer cement impregnated with different concentrations (0.5%, 1.25% and 2.5%) of a non releasing bactericide –Triclosan (TC) against two common cariogenic bacteria – Lactobacillus acidophilus and Streptococcus mutans; and to compare Triclosan incorporated GIC with chlorhexidine (CHX) incorporated GIC (2.5%)in terms of antibacterial activity. Methods: Chlorhexidine or Triclosan were added to glass ionomer cement powder to achieve 2.5% CHX – GIC (positive control – Group II), 0.5%, 1.25% and 2.5% TC-GIC (experimental groups III, IV and V respectively) formulations. Restorative glass ionomer cement (Fuji IX GC –Group I) served as negative control. The powder and liquid were mixed and inserted into the wells punched in agar plates (10mm × 4mm). The agar diffusion method was used to determine the antibacterial activity of the cements after 1, 7 and 30 days. Mean values were compared between different study groups using One-way ANOVA and Tukey's HSD procedure at a significance level of 5%. Results: Triclosan incorporated GIC was more effective against L.acidophilus and S.mutans than Chlorhexidine incorporated GIC. Triclosan at a concentration of 2.5% was more effective than at lower concentrations. At all time periods studied, the maximum zone of inhibition against L.acidophilus was produced by Group V. Against S.mutans, on days 1,7 and 30, there was no significant difference between Groups II and IV (p>0.05), while the other groups showed significant differences. Conclusion: The use of triclosan as an antibacterial additive in GIC holds promise and further clinical research is needed in this direction.


2012 ◽  
Vol 57 (1) ◽  
pp. 58-64 ◽  
Author(s):  
X Du ◽  
X Huang ◽  
C Huang ◽  
JE Frencken ◽  
T Yang

2008 ◽  
Vol 16 (2) ◽  
pp. 155-160 ◽  
Author(s):  
Terezinha Jesus Esteves Barata ◽  
Eduardo Bresciani ◽  
Maria Cecília Ribeiro Mattos ◽  
José Roberto Pereira Lauris ◽  
Dan Ericson ◽  
...  

2015 ◽  
Vol 6 ◽  
pp. CMPsy.S20765
Author(s):  
Murielle Girard ◽  
Karine Vuilliers-Devillers ◽  
Emilie Pinault ◽  
Barbara Bessette ◽  
Brigitte Plansont ◽  
...  

We investigated the serum protein profiles of subjects with major depressive disorder (MDD), with (n = 4) and without clinical improvement (n = 4), at the initiation of antidepressant treatment (venlafaxine) (T0) and 4 weeks later (T28), by difference gel electrophoresis in two dimensions (2D-DIGE) and mass spectrometry. The nine proteins displaying differences in composition between the two time points in the group with clinical improvement between T0 and T28 included gelsolin, clusterin, and the activated fragment of complement C3 (C3a). We then analyzed serum samples from MDD subjects receiving different antidepressants between T0 and T28. Subjects were classified into two groups, with (n = 17) or without (n = 14) clinical improvement (>50% decrease in baseline Hamilton Depression Rating Scale score), at T28. Clusterin levels did not differ between groups at either time point. Gelsolin and C3a levels differed between T0 and T28 only in the group presenting clinical improvement. A comparison with serum samples from controls suggested that the levels of these two proteins changed during MDD and were potentially modified after successful antidepressant treatment. Despite the small sample size, the results of this pilot study suggest that several changes in the expression of some serum proteins occur in association with the clinical relevance of the treatment, and indicate changes to general pathways requiring further study.


2006 ◽  
Vol 64 (1) ◽  
pp. 37-41 ◽  
Author(s):  
Letícia Algarves Miranda ◽  
Sabrina Carvalho Gomes ◽  
Ilson José Soares ◽  
Rui Vicente Oppermann

1992 ◽  
Vol 25 (5) ◽  
pp. 238-244 ◽  
Author(s):  
W. P. SAUNDERS ◽  
E. M. SAUNDERS ◽  
D. HERD ◽  
E. STEPHENS

Sign in / Sign up

Export Citation Format

Share Document